Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bladder Cancer

  Free Subscription


09.07.2018

1 Adv Clin Exp Med
1 Ann Surg Oncol
1 ANZ J Surg
1 Biochem Biophys Res Commun
1 Biomed Pharmacother
1 Cancer Immunol Immunother
1 Cancer Manag Res
1 Cell Physiol Biochem
1 Clin Radiol
1 Environ Sci Pollut Res Int
1 Exp Cell Res
1 Int J Cancer
1 Int J Clin Oncol
1 Int J Nanomedicine
1 Methods Mol Biol
1 Minerva Urol Nefrol
1 Mol Biol Rep
1 Oncogene
1 Oncol Lett
1 Oncotarget
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Adv Clin Exp Med

  1. LEMANSKA-PEREK A, Lis-Kuberka J, Lepczynski A, Dratwa-Chalupnik A, et al
    Potential plasma biomarkers of bladder cancer identified by proteomic analysis: A pilot study.
    Adv Clin Exp Med. 2018 Jul 2. doi: 10.17219/acem/79296.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  2. MUKHERJEE N, Svatek R
    Cancer Immune Therapy: Prognostic Significance and Implications for Therapy of PD-1 in BCG-Relapsing Bladder Cancer.
    Ann Surg Oncol. 2018 Jul 3. pii: 10.1245/s10434-018-6610.
    PubMed     Text format    


    ANZ J Surg

  3. LI Z, Li Y, Lu Q, Chen J, et al
    Value of repeat radical transurethral resection for selected patients with muscle-invasive bladder cancer.
    ANZ J Surg. 2018 Jul 5. doi: 10.1111/ans.14709.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  4. DONG BW, Zhang WB, Qi SM, Yan CY, et al
    Transactivation of PTGS2 by PAX5 signaling potentiates cisplatin resistance in muscle-invasive bladder cancer cells.
    Biochem Biophys Res Commun. 2018 Jun 28. pii: S0006-291X(18)31470.
    PubMed     Text format     Abstract available


    Biomed Pharmacother

  5. HANZE J, Kessel F, Di Fazio P, Hofmann R, et al
    Effects of multi and selective targeted tyrosine kinase inhibitors on function and signaling of different bladder cancer cells.
    Biomed Pharmacother. 2018;106:316-325.
    PubMed     Text format     Abstract available


    Cancer Immunol Immunother

  6. OBARA W, Hara I, Kato Y, Kato R, et al
    Immunotherapy with cancer peptides in combination with intravesical bacillus Calmette-Guerin for patients with non-muscle invasive bladder cancer.
    Cancer Immunol Immunother. 2018 Jul 3. pii: 10.1007/s00262-018-2197.
    PubMed     Text format     Abstract available


    Cancer Manag Res

  7. YAN H, Xie H, Ying Y, Li J, et al
    Pioglitazone use in patients with diabetes and risk of bladder cancer: a systematic review and meta-analysis.
    Cancer Manag Res. 2018;10:1627-1638.
    PubMed     Text format     Abstract available


    Cell Physiol Biochem

  8. HOU T, Zhou L, Wang L, Kazobinka G, et al
    Leupaxin Promotes Bladder Cancer Proliferation, Metastasis, and Angiogenesis Through the PI3K/AKT Pathway.
    Cell Physiol Biochem. 2018;47:2250-2260.
    PubMed     Text format     Abstract available


    Clin Radiol

  9. SEVCENCO S, Maj-Hes AB, Hruby S, Ponhold L, et al
    Apparent diffusion coefficient values obtained by unenhanced MRI predicts disease-specific survival in bladder cancer.
    Clin Radiol. 2018 Jun 30. pii: S0009-9260(18)30215.
    PubMed     Text format     Abstract available


    Environ Sci Pollut Res Int

  10. HAMEED DA, Yassa HA, Agban MN, Hanna RT, et al
    Correction to: Genetic aberrations of the K-ras proto-oncogene in bladder cancer in relation to pesticide exposure.
    Environ Sci Pollut Res Int. 2018 Jul 3. pii: 10.1007/s11356-018-2639.
    PubMed     Text format     Abstract available


    Exp Cell Res

  11. LIU Y, Ding M, Liao X, Gao Q, et al
    High expression of enhancer RNA MARC1 or its activation by DHT is associated with the malignant behavior in bladder cancer.
    Exp Cell Res. 2018 Jun 28. pii: S0014-4827(18)30373.
    PubMed     Text format     Abstract available


    Int J Cancer

  12. LIN C, Travis RC, Appleby PN, Tipper S, et al
    Pre-diagnostic circulating insulin-like growth factor-I and bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition.
    Int J Cancer. 2018 Jul 4. doi: 10.1002/ijc.31650.
    PubMed     Text format     Abstract available


    Int J Clin Oncol

  13. KOJIMA T, Nishiyama H, Ozono S, Hinotsu S, et al
    Clinical evaluation of two consecutive UroVysion fluorescence in situ hybridization tests to detect intravesical recurrence of bladder cancer: a prospective blinded comparative study in Japan.
    Int J Clin Oncol. 2018 Jul 3. pii: 10.1007/s10147-018-1311.
    PubMed     Text format     Abstract available


    Int J Nanomedicine

  14. SHIN SS, Noh DH, Hwang B, Lee JW, et al
    Inhibitory effect of Au@Pt-NSs on proliferation, migration, and invasion of EJ bladder carcinoma cells: involvement of cell cycle regulators, signaling pathways, and transcription factor-mediated MMP-9 expression.
    Int J Nanomedicine. 2018;13:3295-3310.
    PubMed     Text format     Abstract available


    Methods Mol Biol

  15. RAMSEY SA
    A Method for Cross-Species Visualization and Analysis of RNA-Sequence Data.
    Methods Mol Biol. 2018;1702:291-305.
    PubMed     Text format     Abstract available


    Minerva Urol Nefrol

  16. HURLE R, Buffi N, Lista G, Cardone P, et al
    Long-term outcomes of high grade T1 bladder cancer treated with intravesical Bacille Calmette-Guerin therapy: a single-institutional experience.
    Minerva Urol Nefrol. 2018 Jul 3. pii: S0393-2249.18.03042.
    PubMed     Text format     Abstract available


    Mol Biol Rep

  17. JAMALI E, Barani S, Yousefinejad F, Ariafar A, et al
    KIRs gene content diversity in Iranians with urothelial bladder cancer.
    Mol Biol Rep. 2018 Jul 2. pii: 10.1007/s11033-018-4221.
    PubMed     Text format     Abstract available


    Oncogene

  18. LEE E, Collazo-Lorduy A, Castillo-Martin M, Gong Y, et al
    Identification of microR-106b as a prognostic biomarker of p53-like bladder cancers by ActMiR.
    Oncogene. 2018 Jul 3. pii: 10.1038/s41388-018-0367.
    PubMed     Text format     Abstract available


    Oncol Lett

  19. WEI W, Wang M, Li Y, Meng Q, et al
    Muscarinic cholinergic signaling and overactive bladder-like symptoms associated with invasive bladder cancer.
    Oncol Lett. 2018;16:775-784.
    PubMed     Text format     Abstract available


    Oncotarget

  20. LEE JY, Yun SJ, Jeong P, Piao XM, et al
    Identification of differentially expressed miRNAs and miRNA-targeted genes in bladder cancer.
    Oncotarget. 2018;9:27656-27666.
    PubMed     Text format     Abstract available


    PLoS One

  21. HARTANA CA, Ahlen Bergman E, Zirakzadeh AA, Krantz D, et al
    Urothelial bladder cancer may suppress perforin expression in CD8+ T cells by an ICAM-1/TGFbeta2 mediated pathway.
    PLoS One. 2018;13:e0200079.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: